Boston Scientific Corporation (BSX) — Stock Score Summary

Boston Scientific Corporation (BSX) has a MoatMap StockRank of 52/100 based on Quality (67/100), Value (42/100), and Momentum (28/100) factor scores. The current signal is HOLD. Boston Scientific is a high-quality medical device manufacturer with strong market share. However, it is fully valued and lacks a specific, unpriced macro inflection tailwind to drive asymmetric upside over our 18-month horizon.

Boston Scientific Corporation is a global developer, manufacturer, and marketer of interventional medical devices across specialties including cardiology, peripheral interventions, urology, and gastrointestinal health. The company maintains a strong competitive position through its robust R&D pipeline, extensive patent portfolio, and deep-rooted relationships with healthcare systems, which drive high switching costs for its advanced solutions. As a significant player in the medical technology sector, it consistently introduces innovative, life-changing devices.

Key Financial Metrics

Price$48.65
Market Cap$73.0B
P/E (TTM)20.44
P/E (Forward)13.10
Price/Book2.81
Return on Equity14.7%
Return on Invested Capital9.8%
Debt/Equity42.25
Gross Margin68.9%
Operating Margin20.6%
Revenue Growth11.6%
Free Cash Flow$2.8B

Boston Scientific Corporation operates in the Medical Devices industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Boston Scientific Corporation’s (BSX) StockRank?
MoatMap’s StockRank for Boston Scientific Corporation (BSX) is 52/100, with a Hold signal. It is a composite of Quality (67), Value (42), and Momentum (28) factor ranks across MoatMap’s 19,000+ stock universe.
Does Boston Scientific Corporation have an economic moat?
Boston Scientific Corporation (BSX) has a Quality factor score of 67/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Boston Scientific Corporation a buy, hold, or sell?
MoatMap’s current signal for Boston Scientific Corporation (BSX) is Hold, based on a StockRank of 52/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Boston Scientific Corporation in?
Boston Scientific Corporation (BSX) operates in the Healthcare sector, specifically the Medical Devices industry (United States).
Browse all ranked stocksBSX deep dive reportAI ChampionsHow we score stocksSense-check another stock